AI Companies Are Calling for More Regulation. Why They Stand to Benefit the Most
AI executives across the industry, led by Anthropic CEO Dario Amodei, called for a coordinated slow down in AI development over the weekend. The move followed a viral post on X from a former Anthropic...
15 Syys 16min
Why Canada Is Cozying Up to Europe
In the midst of a trade war with the US, Canadian Prime Minister Mark Carney is on a charm offensive. On today’s Big Take podcast, Bloomberg’s Derek Decloet and host David Gura break down how Canada i...
14 Syys 18min
LIV Golf’s $5 Billion Path to Bankruptcy
LIV Golf split the professional circuit early this decade with its flashy tournaments and payouts that outstripped what golfers were earning on PGA tours. Now, after five years — and more than $5 bill...
13 Syys 16min
How India Is Training the Robots of the Future
Tens of thousands of workers in India are wearing head-mounted cameras to record their every move, helping train humanoid robots to perform everyday human tasks. On today’s Big Take Asia podcast, Bloo...
11 Syys 17min
So Could AI 'Kill Us All'?
"The people building AI earnestly believe that it could kill us all by the end of the decade." An X post by a former employee of both OpenAI and Anthropic went viral and is prompting big questions. On...
10 Syys 15min
Trump Needs a Win. Enter His Venezuela Oil Deal
Oil prices topped $100 per barrel on Wednesday, keeping gas prices and the Iran war at the center of the US midterms conversation. Can President Trump burnish his affordability credentials with what h...
9 Syys 17min
Why the Bond Market Has Everyone On Edge
The bond market has been grabbing headlines and roiling global markets, particularly in the US and in Japan, where yields are surging and buyer interest remains low. That matters, because as Bloomberg...
8 Syys 16min
Americans Are Spending Billions to Help Their Pets Live Longer
The wellness and longevity boom has come for a new kind of consumer: your pet. But with clinical trials still underway and questions lingering about the safety and efficacy of off-label drugs and trea...
4 Syys 18min
